Today: 19 May 2026
First Solar stock jolts traders after weak 2026 outlook; tariffs and permitting delays loom
25 February 2026
2 mins read

First Solar stock jolts traders after weak 2026 outlook; tariffs and permitting delays loom

New York, Feb 25, 2026, 05:22 (ET) — Premarket

First Solar shares tumbled close to 14% in after-hours trading Tuesday after the company forecast 2026 net sales between $4.9 billion and $5.2 billion—well shy of the $6.12 billion analysts were looking for. Citing “federal permitting approval delays” affecting customers, the U.S. solar panel maker also flagged an expected $125 million to $135 million tariff impact in 2026. Reuters

Guidance like this carries weight in a market where policy decisions directly steer both demand and expense. For U.S. solar supply chains, permitting timelines, tariffs, and tax credits aren’t just afterthoughts—they’ve become the playbook itself.

Investors now have to gauge if Tuesday’s after-hours move holds up when cash trading kicks off—or if it loses steam as buyers point to backlog and balance-sheet muscle. One thing’s clear: FSLR is staring down a choppy open after a calm day in regular hours.

First Solar shares finished Tuesday’s regular session at $243.21, a gain of 0.44%. The stock saw intraday swings from $238.55 to $250.99, with roughly 3.34 million shares traded.

First Solar, based in Phoenix, posted 2025 net sales of $5.2 billion in its earnings release, with $1.7 billion logged for the fourth quarter. Net income for the quarter landed at $4.84 per diluted share. Looking ahead to 2026, the company forecasted sales volume in a range of 17.0 to 18.2 gigawatts (GW), the standard measure of solar capacity, and projected adjusted EBITDA between $2.6 billion and $2.8 billion—this figure excludes interest, taxes, and some non-cash items.

Baird analysts lowered their rating on First Solar, shifting to “Neutral” from “Outperform” and slashing the price target to $205, down from $264. They cited ongoing uncertainty in the company’s outlook, and pointed to shifting trade and regulatory factors. In their note, Baird highlighted unresolved issues surrounding Section 232—U.S. trade powers that may trigger tariffs—and questions over “foreign entity of concern” rules that determine which supply chains remain eligible for incentives. Investing.com

First Solar and Oxford PV have struck a U.S.-centered patent licensing deal involving perovskites, a semiconductor material seen as key to the next leap in solar tech. “This agreement allows us to continue pursuing viable pathways to manufacturing and commercializing thin film-perovskite products,” said CEO Mark Widmar. Oxford PV’s chief executive, David Ward, called robust IP protection “essential to supporting innovation at scale across the solar industry.” The companies announced the agreement in a joint statement. Business Wire

Trade tensions are still front and center. Citing a Reuters report, Indian manufacturers are now facing uncertainty after President Donald Trump’s freeze on project approvals left thousands of megawatts of clean power projects in limbo. That’s yet another snag on top of the permitting holdups First Solar has already highlighted. “The manufacturers have been anticipating U.S. tariffs… even before the investigation was first launched in August 2025,” Fei Chen, a solar research analyst at Rystad Energy, told Reuters. Reuters

Still, the outlook isn’t locked. Permitting delays can upend timelines, pushing projects and module shipments further out. Should tariffs expand or costs outpace prices, even manufacturers with a U.S. focus could see margin pressure. Traders are eyeing any shift from cautious forecasts to cautious dealmaking.

Another trade deadline just landed. On Tuesday, the U.S. Commerce Department slapped countervailing duties—anti-subsidy tariffs—on solar cells and panels coming in from India, Indonesia and Laos. Subsidy rates: 125.87% for India, 104.38% for Indonesia, and 80.67% for Laos. Together, those three countries shipped $4.5 billion worth of solar products to the U.S. last year, according to Reuters. Tim Brightbill, the main lawyer for the Alliance for American Solar Manufacturing and Trade, called the action “an important step toward restoring fair competition.” The department has a separate anti-dumping ruling set for next month, and it’s aiming for a final call on the countervailing tariffs in July. Reuters

Stock Market Today

  • New 2024 Legislation Challenges Traditional 6% Real Estate Commissions
    May 19, 2026, 6:12 AM EDT. In 2024, new legislation aims to disrupt the standard 6% commission model in real estate sales. This change targets commissions on high-value properties like a $1 million Maui home. Sellers may see reduced agent fees as the law encourages more competitive pricing structures, potentially saving thousands of dollars. The shift reflects increasing pressure on traditional real estate agents to adjust their commission rates in a changing market landscape.

Latest articles

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Tesla Slides Again as Robotaxi Faces Latest Challenge

Tesla Slides Again as Robotaxi Faces Latest Challenge

18 May 2026
Tesla shares fell 3.8% to $406.11 Monday as tech stocks slid and bond yields rose. The company raised U.S. Model Y prices over the weekend, its first increase in two years. Elon Musk said Tesla expects to expand cars without human safety monitors across the U.S. later this year. Reuters tests of Tesla robotaxis in Texas found long waits and limited availability.
MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI
Previous Story

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

Fermi Inc (FRMI) stock price rises premarket as REIT tax risk and earnings date grab attention
Next Story

Fermi Inc (FRMI) stock price rises premarket as REIT tax risk and earnings date grab attention

Go toTop